OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
Ruixue Kong, Lulu Sun, Hua Li, et al.
Autoimmunity (2021) Vol. 55, Iss. 1, pp. 1-7
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus
Xiaoxiao Wu, Junhao Yang, Juanjie Wu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116261-116261
Open Access | Times Cited: 9

Pyroptosis-Mediated Periodontal Disease
Mariane Beatriz Sordi, Ricardo de Souza Magini, Layla Panahipour, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 372-372
Open Access | Times Cited: 51

SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases
Regina Larionova, K. Byvaltsev, О. А. Кравцова, et al.
Journal of Translational Autoimmunity (2022) Vol. 5, pp. 100154-100154
Open Access | Times Cited: 20

NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation
Bo‐Zong Shao, Haiyan Xu, Yicheng Zhao, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 35-46
Closed Access | Times Cited: 19

Abietane diterpenoids from Orthosiphon wulfenioides with NLRP3 inflammasome inhibitory activity
Wen‐Chao Tu, Ying-Xin Zhao, Changlin Yang, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106534-106534
Closed Access | Times Cited: 11

The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases
Mina Dadkhah, Mohammadreza Sharifi
International Reviews of Immunology (2024) Vol. 44, Iss. 2, pp. 98-111
Closed Access | Times Cited: 4

Neuroinflammation in kidney disease and dialysis
Yumi Watanabe Chagas, Pedro Alves Soares Vaz de Castro, Ana Cristina Simões e Silva
Behavioural Brain Research (2025) Vol. 483, pp. 115465-115465
Closed Access

Novel regulatory role of non-coding RNAs in ankylosing spondylitis
Yanyan Fang, Jian Liu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10

Significance of pyroptosis-related gene in the diagnosis and classification of rheumatoid arthritis
Jian Li, Yongfeng Cui, Xin Jin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10

Diterpenoids with a novel 6/5-5 spiro tricyclic skeleton from Orthosiphon wulfenioides and their NLRP3 inflammasome inhibitory activity
Wen‐Chao Tu, Xing‐Jie Zhang, Ying-Xin Zhao, et al.
Organic Chemistry Frontiers (2023) Vol. 10, Iss. 12, pp. 2898-2906
Closed Access | Times Cited: 10

A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease
Shuting Zhuang, Danchun Guo, Dingle Yu
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access

Targeting inflammasome-dependent mechanisms as an emerging pharmacological approach for osteoarthritis therapy
Sergio Ramírez-Pérez, Itzel Viridiana Reyes‐Pérez, Diana Fernández, et al.
iScience (2022) Vol. 25, Iss. 12, pp. 105548-105548
Open Access | Times Cited: 16

Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations
Yuliya Fedorchenko, Khaiyom Mahmudov, Zhumabek Abenov, et al.
Rheumatology International (2023) Vol. 43, Iss. 12, pp. 2167-2174
Closed Access | Times Cited: 9

Review of potential medical treatments for middle ear cholesteatoma
Matthias Schürmann, Peter Goon, Holger Sudhoff
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 14

Modulation of apoptosis and Inflammasome activation in chondrocytes: co-regulatory role of Chlorogenic acid
Muhammad Fakhar‐e‐Alam Kulyar, Quan Mo, Wangyuan Yao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Magnesium-enriched deep-sea water inhibits NLRP3 inflammasome activation and dampens inflammation
Hsueh-Hsiao Wang, Chi‐Ruei Huang, Hsin‐Chung Lin, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35136-e35136
Open Access | Times Cited: 2

Kaempferol alleviates rheumatoid arthritis through pyroptosis based on bioinformatics analysis and experimental validation
Yi Ling, Nina Ren, Yuzheng Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

“Other Than NLRP3” Inflammasomes: Multiple Roles in Brain Disease
Anna Chiarini, Ubaldo Armato, Li Gui, et al.
The Neuroscientist (2022) Vol. 30, Iss. 1, pp. 23-48
Closed Access | Times Cited: 11

Knockdown of NEK7 alleviates anterior cruciate ligament transection osteoarthritis (ACLT)-induced knee osteoarthritis in mice via inhibiting NLRP3 activation
Wei Sun, Maoxing Yue, Guangmin Xi, et al.
Autoimmunity (2022) Vol. 55, Iss. 6, pp. 398-407
Closed Access | Times Cited: 9

Identification of Key Genes for Pyroptosis-Induced Salivary Gland Inflammation in Sjogren’s Syndrome Based on Microarray Data and Immunohistochemistry Analysis
Kaiyuan Zhang, Ziyue Luo, Xinchao Zhu, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5865-5879
Open Access | Times Cited: 4

The role of Gαq in regulating NLRP3 inflammasome activation
Ruixue Kong, Lijun Peng, Hua Bao, et al.
Inflammation Research (2024) Vol. 73, Iss. 12, pp. 2249-2261
Closed Access | Times Cited: 1

A comprehensive review of Sjögren's syndrome: classification criteria, risk factors, and signaling pathways
Ting Zhao, Runrun Zhang, Zhaofu Li, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36220-e36220
Open Access | Times Cited: 1

Chalcone Derivatives From Abelmoschus manihot Seeds Restrain NLRP3 Inflammasome Assembly by Inhibiting ASC Oligomerization
Jinsong Su, Fujing Yang, Xuemei Kang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top